When was InVivo Biosystems founded?

InVivo Biosystems was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is InVivo Biosystems located?

InVivo Biosystems is headquartered in Eugene, United States. It is registered at A2, AGARWAL APARTMENTS,3-4-485/A2, BARKTPURA, HYDERABAD-27., HYDERABAD-27., Telangana, India, 000000.

Which legal entities is InVivo Biosystems associated with?

InVivo Biosystems is associated with INVITRO BIO SYSTEMS PRIVATE LIMITED.

How many employees does InVivo Biosystems have?

As of Aug 31, 2026, the latest employee count at InVivo Biosystems is 40.

Is InVivo Biosystems a funded company?

InVivo Biosystems is a funded company, having raised a total of $8.16M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Feb 27, 2019.

When was the latest funding round of InVivo Biosystems?

InVivo Biosystems' latest funding was a $***** Grant (prize money) round on Feb 26, 2025, with participation from 1 investor.

What is the annual revenue of InVivo Biosystems?

Annual revenue of InVivo Biosystems is between ₹10 Cr and ₹50 Cr as on Mar 31, 2025

Where does InVivo Biosystems rank among its competitors?

InVivo Biosystems ranks 7th amongst 162 active competitors, of which 16 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Magnitude Biosciences, which secured an undisclosed amount in May, 2025.

Who are the top competitors of InVivo Biosystems?

InVivo Biosystems' top competitors include Biocytogen, Applied StemCell and TransCure bioServices. Among them, Magnitude Biosciences secured the most recent funding round in May, 2025.

InVivo Biosystems - 2026 Company Profile, Team, Funding, Competitors & Financials

InVivo Biosystems is a series A company based in Eugene (United States), founded in 2019 by Janis Weeks. It operates as a Provider of animal models for in-vivo analytical services. InVivo Biosystems has raised $8.16M in funding from Rogue Venture Partners. The company has 162 active competitors, including 16 funded and 26 that have exited. Its top competitors include companies like Biocytogen, Applied StemCell and TransCure bioServices.

Company Details

InVivo Biosystems provider of animal models for in-vivo analytical services. The company's disease model includes C. elegance for transgenic services and Zebrafish for genome editing services. It also offers assay kit, reagents like PCR master mix, custom in-vivo testing and in-vivo toxicity testing.

Website: invivobiosystems.com
Registered Address: A2, AGARWAL APARTMENTS,3-4-485/A2, BARKTPURA, HYDERABAD-27., HYDERABAD-27., Telangana, India, 000000

Key Metrics

Founded Year

2019

Location

Eugene, United States

Stage

Series A

Total Funding

$8.16M in 6 rounds

Latest Funding Round

Grant (prize money), Feb 26, 2025, $*****

Investors

Rogue Venture Partners & 7 more

Ranked

7^th among 162 active competitors

Annual Revenue

₹10 - ₹50 Cr as on Mar 31, 2025

Employee Count

40 as on Aug 31, 2026

Similar Companies

Biocytogen & 57 more

View InVivo Biosystems' full profile

InVivo Biosystems is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
INVITRO BIO SYSTEMS PRIVATE LIMITED CIN: U52520TG2004PTC043567 , India, Active	Jul 01, 2004	₹10 - ₹50 Cr (As on Mar 31, 2025)	-

InVivo Biosystems has raised a total funding of $8.16M over 6 rounds. Its first funding round was on Feb 27, 2019. Its latest funding round was a Grant (prize money) round on Feb 26, 2025 for $*****. 1 investor participated in its latest round. InVivo Biosystems has 8 institutional investors.

Here is the list of recent funding rounds of InVivo Biosystems:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 26, 2025	6476781	Grant (prize money)	8024009	2313628	1956179	3424768
Feb 07, 2025	2313457	Grant (prize money)	9065999	4645805	7437447	HHS
Jan 02, 2025	3741037	Grant (prize money)	6361558	7114784	9964298	HHS

Access funding benchmarks and valuations. Sign up today!

View details of InVivo Biosystems's funding rounds and investors

The founders of InVivo Biosystems is Janis Weeks.

Here are the details of InVivo Biosystems' key team members:

Janis Weeks: Co-Founder of InVivo Biosystems.
Contact Info: 1 email address

View details of InVivo Biosystems's Founder profiles and Board Members

InVivo Biosystems' employee count trend

InVivo Biosystems has 40 employees as of Aug 26. Here is InVivo Biosystems's employee count trend over the years:

Employee count trend for InVivo Biosystems

Uncover InVivo Biosystems' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of InVivo Biosystems include Biocytogen, Applied StemCell and TransCure bioServices. Here is the list of Top 10 competitors of InVivo Biosystems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biocytogen 2008, Wakefield (United States), Public	Provider of integrated solutions for next-generation antibody drug development	$301M	CMB International Capital, SDIC & 11 others	67/100
2nd	Applied StemCell 2008, Milpitas (United States), Acquired	Provider of animal and cell line models as tools for drug discovery and diagnostics	$67.5M	Fosun, Advantech Capital & 8 others	60/100
3rd	TransCure bioServices 2012, Archamps (France), Series B	Developer of humanized animal models for preclinical studies	$3.58M	Financiere Arbevel, Savoie Mont Blanc Angels ... & 5 others	59/100
4th	GenOway 1999, Lyon (France), Public	Provider of transgenic rodent models and customized cell lines for preclinical development	$11.6M	Eurostars, Dassault Developpement & 7 others	58/100
5th	Taconic 1952, Hudson (United States), Acquired	Provider of animal models and laboratory services	-	HIG BioHealth Partners, Falcon Investment Advisors	51/100
6th	Cyagen 2005, Santa Clara (United States), Series B	Contract research organization for cell culture product and animal model manufacturer	$40.5M	China Merchants Securities, GF Qianhe Investment ... & 2 others	49/100
7th	InVivo Biosystems 2019, Eugene (United States), Series A	Provider of animal models for in-vivo analytical services	$8.16M	Oregon Venture Fund, Cascade Seed Fund & 6 others	46/100
8th	Magnitude Biosciences 2018, Durham (United Kingdom), Seed	Provider of early in vivo whole-organism high-throughput phenotypic screening and follow-up assays for drug discovery	$2.6M	Northstar Ventures, Saker Capital & 10 others	46/100
9th	Alpha Genesis 2003, Yemassee (United States), Series B	Preclinical research services specializing in nonhuman primate models for therapy development	$12.5M	-	45/100
10th	Kimera Labs 2012, Miramar (United States), Unfunded	Developer of perinatal exosome products for research and therapeutic purposes	-	-	42/100